428 related articles for article (PubMed ID: 13505250)
1. [Raynaud's syndrome and scleroderma. I. Scleroderma-like changes in Raynaud's syndrome and their differentiation from scleroderma].
JABLONSKA S; LUKASIAK B; BUBNOW B
Pol Tyg Lek (Wars); 1957 Sep; 12(39):1481-6. PubMed ID: 13505250
[No Abstract] [Full Text] [Related]
2. Raynaud's phenomenon, scleroderma, overlap syndromes, and other fibrosing syndromes.
Curr Opin Rheumatol; 1997 Nov; 9(6):B199-206. PubMed ID: 9375289
[No Abstract] [Full Text] [Related]
3. Raynaud's phenomenon, scleroderma, overlap syndromes, and other fibrosing syndromes.
LeRoy EC
Curr Opin Rheumatol; 1992 Dec; 4(6):821-4. PubMed ID: 1457276
[No Abstract] [Full Text] [Related]
4. [Raynaud's disease--Raynaud's syndrome].
Trübestein G; Sobbe A
Med Klin; 1974 Nov; 69(48):1990-5. PubMed ID: 4453292
[No Abstract] [Full Text] [Related]
5. Diffuse scleroderma and Raynaud's disease.
JABLONSKA S; BUBNOW B; SZCZEPANSKI A
Br J Dermatol; 1962 May; 74():174-82. PubMed ID: 14450537
[No Abstract] [Full Text] [Related]
6. [Use of plethysmography for the evaluation of peripheral blood vessels with particular reference to Raynaud's disease and conditions preceding scleroderma].
Stroińska W
Przegl Dermatol; 1967; 54(4):463-9. PubMed ID: 6052346
[No Abstract] [Full Text] [Related]
7. [Scleroderma and Raynaud's phenomenon: current pathogenetic interpretations and clinico-therapeutic trends].
Zelli GP; Cannata P
Ann Ital Chir; 1981; 53(3):337-43. PubMed ID: 7337317
[No Abstract] [Full Text] [Related]
8. Raynaud's phenomenon and scleroderma.
Harper FE; LeRoy EC
Compr Ther; 1981 Feb; 7(2):45-51. PubMed ID: 6163587
[No Abstract] [Full Text] [Related]
9. Raising awareness of Raynaud's phenomenon and scleroderma.
Mawdsley AH; Brown SJ
Nurs Times; 2005 Feb 22-28; 101(8):30-1. PubMed ID: 15754937
[TBL] [Abstract][Full Text] [Related]
10. [Recent advances in Raynaud's syndrome].
Klein-Weigel P
Dtsch Med Wochenschr; 2012 Mar; 137(13):622-4. PubMed ID: 22434167
[No Abstract] [Full Text] [Related]
11. Raynaud's syndrome: diagnosis and management.
Birnstingl M
Br J Hosp Med; 1979 Jun; 21(6):602-6, 611. PubMed ID: 476333
[No Abstract] [Full Text] [Related]
12. Clinical implications from capillaroscopic analysis in patients with Raynaud's phenomenon and systemic sclerosis.
Herrick AL; Cutolo M
Arthritis Rheum; 2010 Sep; 62(9):2595-604. PubMed ID: 20506306
[No Abstract] [Full Text] [Related]
13. Prognostic significance of Raynaud's phenomenon and other clinical characteristics of systemic scleroderma. A study of 271 cases.
FARMER RG; GIFFORD RW; HINES EA
Circulation; 1960 Jun; 21():1088-95. PubMed ID: 13821594
[No Abstract] [Full Text] [Related]
14. Beyond Raynaud's phenomenon hides very early systemic sclerosis: the assessment of organ involvement is always mandatory.
Czirják L; Matucci-Cerinic M
Rheumatology (Oxford); 2011 Feb; 50(2):250-1. PubMed ID: 21115465
[No Abstract] [Full Text] [Related]
15. Unilateral limited scleroderma-like changes following formation of an arteriovenous fistula.
Roberts H; Curnow PA
Australas J Dermatol; 2007 Feb; 48(1):37-9. PubMed ID: 17222301
[TBL] [Abstract][Full Text] [Related]
16. Systemic sclerosis.
Ng SC
Singapore Med J; 1992 Apr; 33(2):189-92. PubMed ID: 1621127
[TBL] [Abstract][Full Text] [Related]
17. Low plasma protein nitrotyrosine levels distinguish primary Raynaud's phenomenon from scleroderma.
Kingdon EJ; Mani AR; Frost MT; Denton CP; Powis SH; Black CM; Moore KP
Ann Rheum Dis; 2006 Jul; 65(7):952-4. PubMed ID: 16308344
[TBL] [Abstract][Full Text] [Related]
18. [Capillaroscopy of the nail fold in Raynaud's phenomenon and scleroderma].
Knobel H; Vilardell M; Marquet R; Ordi J
Med Clin (Barc); 1987 Oct; 89(13):533-6. PubMed ID: 3695683
[No Abstract] [Full Text] [Related]
19. Raynaud's disease.
Birnstingl M
Proc R Soc Med; 1968 Aug; 61(8):790-2. PubMed ID: 5673408
[No Abstract] [Full Text] [Related]
20. [Capillaroscopy and vascular acrosyndromes].
Planchon B; Pistorius MA
J Mal Vasc; 1999 Dec; 24(5):357-62. PubMed ID: 10642647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
